ERBB2 and hydrops fetalis: Notably, we found that specific concomitant intake of anticancer drugs on top of gemcitabine were more likely to be associated with different type of cardiotoxicities such as platins with MI, HER-2 blockers with HF, and immune checkpoint inhibitors with pericardial disorders.